ZA201200295B - Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (rpe) - Google Patents
Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (rpe)Info
- Publication number
- ZA201200295B ZA201200295B ZA2012/00295A ZA201200295A ZA201200295B ZA 201200295 B ZA201200295 B ZA 201200295B ZA 2012/00295 A ZA2012/00295 A ZA 2012/00295A ZA 201200295 A ZA201200295 A ZA 201200295A ZA 201200295 B ZA201200295 B ZA 201200295B
- Authority
- ZA
- South Africa
- Prior art keywords
- leishmaniasis
- rpe
- diagnosis
- ribosomal protein
- protein extract
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56905—Protozoa
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Secondary Cells (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09165282 | 2009-07-13 | ||
US26721409P | 2009-12-07 | 2009-12-07 | |
PCT/EP2010/060058 WO2011006891A1 (en) | 2009-07-13 | 2010-07-13 | Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (rpe) |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201200295B true ZA201200295B (en) | 2012-09-26 |
Family
ID=41211952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2012/00295A ZA201200295B (en) | 2009-07-13 | 2012-01-13 | Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (rpe) |
Country Status (20)
Country | Link |
---|---|
US (1) | US8969019B2 (en) |
EP (1) | EP2454593A1 (en) |
JP (1) | JP5805635B2 (en) |
KR (1) | KR20120061082A (en) |
CN (1) | CN102483413A (en) |
AP (1) | AP3516A (en) |
AU (1) | AU2010272566B2 (en) |
BR (1) | BR112012000679A2 (en) |
CA (1) | CA2767865A1 (en) |
CO (1) | CO6480993A2 (en) |
EC (1) | ECSP12011662A (en) |
IL (1) | IL217528A (en) |
IN (1) | IN2012DN00401A (en) |
MA (1) | MA33514B1 (en) |
MX (1) | MX2012000675A (en) |
PE (1) | PE20120818A1 (en) |
RU (1) | RU2558233C2 (en) |
TN (1) | TN2012000014A1 (en) |
WO (1) | WO2011006891A1 (en) |
ZA (1) | ZA201200295B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SA110310855B1 (en) * | 2009-11-13 | 2014-09-16 | Laboratories Leti S L Unipersonal | The Use of an l3 and/or l5 Source as a Vaccine or as a Diagnostic for a Parasitic Disease |
JP2016053535A (en) * | 2014-09-04 | 2016-04-14 | 国立大学法人 東京大学 | Testing reagent or kit for cutaneous leishmaniasis, and testing method of the same |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5359681A (en) | 1993-01-11 | 1994-10-25 | University Of Washington | Fiber optic sensor and methods and apparatus relating thereto |
US5912166A (en) | 1995-04-21 | 1999-06-15 | Corixa Corporation | Compounds and methods for diagnosis of leishmaniasis |
US6500437B1 (en) * | 1995-09-22 | 2002-12-31 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
US6613337B1 (en) | 1997-02-12 | 2003-09-02 | Corixa Corporation | Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
CN1158387C (en) * | 1998-12-23 | 2004-07-21 | C.B.F.莱蒂股份有限公司 | Chimeric gene encoding the antigenic determinants of four proteins of L.INFANTUM |
EP1624063B1 (en) | 1998-12-23 | 2009-04-22 | Laboratorios LETI, S.L. | Chimeric gene encoding the antigenic determinants of four proteins of L. infantum |
ES2169995B1 (en) | 2000-04-17 | 2003-12-01 | Leti Lab | LIP2A PROTEIN BASED COMPOSITION AND ITS USE IN THE PREPARATION OF A MEDICINAL PRODUCT TO PROVIDE AN IMMUNE RESPONSE AGAINST AN ANTIGEN. |
AU2003270274B2 (en) * | 2002-09-20 | 2009-03-19 | Intervet International B.V. | Live attenuated parasite vaccine |
EP1687023B1 (en) | 2003-11-05 | 2012-10-03 | C.B.F. Leti, S.L. Unipersonal | Use of specific histones for the treatment of parasitic diseases |
-
2010
- 2010-07-13 BR BR112012000679A patent/BR112012000679A2/en not_active IP Right Cessation
- 2010-07-13 EP EP10730190A patent/EP2454593A1/en not_active Withdrawn
- 2010-07-13 AP AP2012006118A patent/AP3516A/en active
- 2010-07-13 IN IN401DEN2012 patent/IN2012DN00401A/en unknown
- 2010-07-13 CA CA2767865A patent/CA2767865A1/en not_active Abandoned
- 2010-07-13 US US13/383,482 patent/US8969019B2/en not_active Expired - Fee Related
- 2010-07-13 PE PE2012000040A patent/PE20120818A1/en not_active Application Discontinuation
- 2010-07-13 JP JP2012520004A patent/JP5805635B2/en not_active Expired - Fee Related
- 2010-07-13 CN CN2010800315957A patent/CN102483413A/en active Pending
- 2010-07-13 AU AU2010272566A patent/AU2010272566B2/en not_active Ceased
- 2010-07-13 WO PCT/EP2010/060058 patent/WO2011006891A1/en active Application Filing
- 2010-07-13 MX MX2012000675A patent/MX2012000675A/en active IP Right Grant
- 2010-07-13 KR KR1020127002828A patent/KR20120061082A/en not_active Application Discontinuation
- 2010-07-13 RU RU2012104855/10A patent/RU2558233C2/en not_active IP Right Cessation
-
2012
- 2012-01-03 CO CO12000715A patent/CO6480993A2/en unknown
- 2012-01-10 TN TNP2012000014A patent/TN2012000014A1/en unknown
- 2012-01-12 IL IL217528A patent/IL217528A/en not_active IP Right Cessation
- 2012-01-13 ZA ZA2012/00295A patent/ZA201200295B/en unknown
- 2012-02-08 MA MA34612A patent/MA33514B1/en unknown
- 2012-02-10 EC ECSP12011662 patent/ECSP12011662A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2454593A1 (en) | 2012-05-23 |
MX2012000675A (en) | 2012-06-08 |
PE20120818A1 (en) | 2012-07-12 |
KR20120061082A (en) | 2012-06-12 |
TN2012000014A1 (en) | 2013-09-19 |
CA2767865A1 (en) | 2011-01-20 |
RU2012104855A (en) | 2013-08-20 |
US20120178109A1 (en) | 2012-07-12 |
CN102483413A (en) | 2012-05-30 |
JP2012533074A (en) | 2012-12-20 |
RU2558233C2 (en) | 2015-07-27 |
MA33514B1 (en) | 2012-08-01 |
ECSP12011662A (en) | 2012-06-29 |
AU2010272566B2 (en) | 2015-03-26 |
JP5805635B2 (en) | 2015-11-04 |
IL217528A0 (en) | 2012-02-29 |
WO2011006891A1 (en) | 2011-01-20 |
AP3516A (en) | 2016-01-11 |
CO6480993A2 (en) | 2012-07-16 |
IN2012DN00401A (en) | 2015-08-21 |
AP2012006118A0 (en) | 2012-02-29 |
BR112012000679A2 (en) | 2016-11-01 |
AU2010272566A1 (en) | 2012-02-02 |
US8969019B2 (en) | 2015-03-03 |
IL217528A (en) | 2016-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0919162D0 (en) | Objective mobility score | |
EP2395839A4 (en) | Anti-fungal formulation | |
PL2084535T3 (en) | Bioinformatic approach to disease diagnosis | |
PL2111555T3 (en) | Diagnosis of preeclampsia | |
GB0908193D0 (en) | Treatment of disease state | |
EP2283031A4 (en) | Lyme disease vaccine | |
EP2640220A4 (en) | Treatment of nail disease | |
GB201007415D0 (en) | Split-cycle engines | |
HRP20170176T1 (en) | The use of an l3 and/or l5 source as a vaccine or as a diagnostic for a parasitic disease | |
EP2304437A4 (en) | Disease specific diagnostic aid | |
IT1395596B1 (en) | PROCEDURE FOR THE PREPARATION OF SITAGLIPTIN | |
ZA201200295B (en) | Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (rpe) | |
IT1399353B1 (en) | PROCEDURE FOR CHOCOLATE PRODUCTION | |
ZA201204182B (en) | Novel glyphosate formulation | |
EP2412811A4 (en) | Dna vaccine for alzheimer's disease | |
IL219967A0 (en) | Sustained-release formulation | |
HU0900199D0 (en) | Diagnosis of gluten-induced autoimmune diseases | |
GB0918782D0 (en) | A protein as an adjuvant for a vaccine | |
GB0903858D0 (en) | Diagnosis of disease | |
ZA201201608B (en) | Parasite harvesting | |
EP2526422A4 (en) | Method of diagnosing sjogren's disease | |
GB0922099D0 (en) | Parasite Vaccine | |
GB0907254D0 (en) | Combating disease | |
GB0908666D0 (en) | Treatment of proteostatic disease | |
GB0917326D0 (en) | Diagnosis of alzheimer's disease |